טוען...

Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

PURPOSE: Prior trials have shown that surgery followed by hepatic artery infusion (HAI) of floxuridine (FUDR) alternating with systemic fluorouracil improves survival rates. Oxaliplatin combined with capecitabine has demonstrated activity in advanced colorectal cancer. Based on this observation a tr...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Alberts, Steven R., Roh, Mark S., Mahoney, Michelle R., O'Connell, Michael J., Nagorney, David M., Wagman, Lawrence, Smyrk, Thomas C., Weiland, Timothy L., Lai, Lily Lau, Schwarz, Roderich E., Molina, Roy, Dentchev, Todor, Bolton, John S.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2010
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834397/
https://ncbi.nlm.nih.gov/pubmed/20048179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.6728
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!